144 related articles for article (PubMed ID: 36196422)
1. Impact of COVID-19 on the curative treatment of prostate cancer: a national cross-sectional study.
Gouveia AG; Moraes FY; Lima RP; Viani GA
Rep Pract Oncol Radiother; 2022; 27(4):659-665. PubMed ID: 36196422
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy activity in the COVID 19 pandemic: Brazil's operational national-level study.
Moraes FY; Gouveia AG; Lima RP; Bratti VF; Hamamura AC; Viani GA
J Cancer Policy; 2023 Jun; 36():100367. PubMed ID: 36216270
[TBL] [Abstract][Full Text] [Related]
3. Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy Regimens.
Aas K; Berge V; Myklebust TÅ; Fosså SD
Eur Urol Open Sci; 2021 Apr; 26():55-63. PubMed ID: 34337508
[TBL] [Abstract][Full Text] [Related]
4. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
[TBL] [Abstract][Full Text] [Related]
5. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
6. Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU - YAU Prostate Cancer Working Group multi-institutional study.
Zattoni F; Marra G; Kretschmer A; Preisser F; Tilki D; Kesch C; Radtke JP; Hoffmann N; Morlacco A; Dal Moro F; Soeterik TFW; van den Bergh RCN; Barletta F; Briganti A; Montorsi F; Gandaglia G
Cent European J Urol; 2021; 74(3):362-365. PubMed ID: 34729226
[TBL] [Abstract][Full Text] [Related]
7. The Comparative Outcomes of Radical Prostatectomy versus Radiotherapy for Nonmetastatic Prostate Cancer: A Longitudinal, Population-Based Analysis.
Oake JD; Shiff B; Harasemiw O; Tangri N; Ferguson TW; Bhindi B; Saranchuk JW; Bansal RK; Drachenberg DE; Nayak JG
J Urol; 2022 Oct; 208(4):846-854. PubMed ID: 32068493
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of biochemical recurrence in patients with high-risk prostate cancer treated with radical prostatectomy and radiotherapy plus androgen deprivation therapy.
Yamamoto Y; Kiba K; Yoshikawa M; Hirayama A; Kunikata S; Uemura H
Res Rep Urol; 2016; 8():225-231. PubMed ID: 27981044
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Predictors of Climacturia and Associated Patient/Partner Bother in Patients With History of Definitive Therapy for Prostate Cancer.
Jimbo M; Alom M; Pfeifer ZD; Haile ES; Stephens DA; Gopalakrishna A; Ziegelmann MJ; Viers BR; Trost LW; Kohler TS
J Sex Med; 2020 Jun; 17(6):1126-1132. PubMed ID: 32179016
[TBL] [Abstract][Full Text] [Related]
10. Cancer-Specific Mortality Among Korean Men with Localized or Locally Advanced Prostate Cancer Treated with Radical Prostatectomy Versus Radiotherapy: A Multi-Center Study Using Propensity Scoring and Competing Risk Regression Analyses.
Koo KC; Cho JS; Bang WJ; Lee SH; Cho SY; Kim SI; Kim SJ; Rha KH; Hong SJ; Chung BH
Cancer Res Treat; 2018 Jan; 50(1):129-137. PubMed ID: 28279064
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiotherapy following radical prostatectomy for prostate cancer.
Daly T; Hickey BE; Lehman M; Francis DP; See AM
Cochrane Database Syst Rev; 2011 Dec; (12):CD007234. PubMed ID: 22161411
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment Patient-reported Overall Health: A Prognostic Factor for Early Overall Mortality After Primary Curative Treatment of Prostate Cancer.
Fosså SD; Holck Storås A; Aas K; Børge Johannesen T; Maria Gjelsvik Y; Myklebust TÅ
Eur Urol Open Sci; 2024 May; 63():62-70. PubMed ID: 38558766
[TBL] [Abstract][Full Text] [Related]
13. Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study.
Fridriksson JÖ; Folkvaljon Y; Nilsson P; Robinson D; Franck-Lissbrant I; Ehdaie B; Eastham JA; Widmark A; Karlsson CT; Stattin P
Scand J Urol; 2016 Oct; 50(5):338-45. PubMed ID: 27333148
[TBL] [Abstract][Full Text] [Related]
14. Cancer-specific survival after metastasis following primary radical prostatectomy compared with radiation therapy in prostate cancer patients: results of a population-based, propensity score-matched analysis.
Shao YH; Kim S; Moore DF; Shih W; Lin Y; Stein M; Kim IY; Lu-Yao GL
Eur Urol; 2014 Apr; 65(4):693-700. PubMed ID: 23759328
[TBL] [Abstract][Full Text] [Related]
15. Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study.
Robinson D; Garmo H; Lissbrant IF; Widmark A; Pettersson A; Gunnlaugsson A; Adolfsson J; Bratt O; Nilsson P; Stattin P
Eur Urol; 2018 Apr; 73(4):502-511. PubMed ID: 29254629
[TBL] [Abstract][Full Text] [Related]
16. Prognostic comparison between radical prostatectomy and radiotherapy in prostate cancer patients at different stages and ages.
Wang F; Fan Y; Yin X; Qi LW; Ma G; Yuan Q
Aging (Albany NY); 2021 Jun; 13(12):16773-16785. PubMed ID: 34185023
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis.
Wang Z; Ni Y; Chen J; Sun G; Zhang X; Zhao J; Zhu X; Zhang H; Zhu S; Dai J; Shen P; Zeng H
World J Surg Oncol; 2020 Feb; 18(1):42. PubMed ID: 32093688
[TBL] [Abstract][Full Text] [Related]
18. Sexual function with localized prostate cancer: active surveillance vs radical therapy.
van den Bergh RC; Korfage IJ; Roobol MJ; Bangma CH; de Koning HJ; Steyerberg EW; Essink-Bot ML
BJU Int; 2012 Oct; 110(7):1032-9. PubMed ID: 22260273
[TBL] [Abstract][Full Text] [Related]
19. Oncological control in high-risk prostate cancer after radical prostatectomy and salvage radiotherapy compared to radiotherapy plus primary hormone therapy.
Caño-Velasco J; Herranz-Amo F; Barbas-Bernardos G; Polanco-Pujol L; Verdú-Tartajo F; Lledó-García E; Hernández-Fernández C
Actas Urol Esp (Engl Ed); 2019 May; 43(4):190-197. PubMed ID: 30878158
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
